Cervical cancer patients with specific changes in the cancer genome have a three- or fourfold increased risk of relapse after standard treatment compared to patients without these changes, according to a study by Norwegian researchers published November 1 ...
Source:
Public Library of Science
Thursday, November 12, 2009